Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Chiron Real Estate ate (3UN0) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:3UN0Chiron Real Estate ateEUR 23.60EUR 350.24M7.26-15.11%Strong BuyUnlock the DE:3UN0 analyst price target with TipRanks PremiumDE:3UN0Unlock the DE:3UN0 top-analyst price target with TipRanks Premium
DHCDiversified Healthcare Trust$7.23$1.77B-11.3251.47%Moderate BuyUnlock the DHC analyst price target with TipRanks PremiumDE:3UN0 vs DHCUnlock the DHC top-analyst price target with TipRanks Premium
CHCTCommunity Healthcare$14.71$423.04M20.131.03%Moderate BuyUnlock the CHCT analyst price target with TipRanks PremiumDE:3UN0 vs CHCTUnlock the CHCT top-analyst price target with TipRanks Premium
UHTUniversal Health Realty Income$38.86$537.64M26.62-1.74%Moderate BuyUnlock the UHT analyst price target with TipRanks PremiumDE:3UN0 vs UHTUnlock the UHT top-analyst price target with TipRanks Premium
STRWStrawberry Fields REIT Inc$12.30$691.79M55.910.16%Moderate BuyUnlock the STRW analyst price target with TipRanks PremiumDE:3UN0 vs STRWUnlock the STRW top-analyst price target with TipRanks Premium
NHPNational Healthcare Properties$15.04$336.11M-13.9325.33%Moderate BuyUnlock the NHP analyst price target with TipRanks PremiumDE:3UN0 vs NHPUnlock the NHP top-analyst price target with TipRanks Premium

Performance Comparison

-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:3UN0Chiron Real Estate ate23.60-4.40-15.71%
DHCDiversified Healthcare Trust7.222.6256.93%
CHCTCommunity Healthcare14.711.3410.00%
UHTUniversal Health Realty Income38.862.185.94%
STRWStrawberry Fields REIT Inc12.300.837.24%
NHPNational Healthcare Properties15.043.1626.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts